skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines donanemabQuestion & answer

donanemab · Medicine question

How is Kisunla (donanemab) administered?

iatroX medicinesPublished 8 November 2026

The answer

Answer

Kisunla (donanemab) is administered only by intravenous infusion over at least 30 minutes, with patients observed for at least 30 minutes afterward.

Sources for this answer

Kisunla 350 mg concentrate for solution for infusionEli Lilly and Company Limited · emc · SmPC §4.2 Posology and method of administration · Version 3Document updated 24 March 2026

Sources checked 8 November 2026

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

More questions about donanemab

Does Kisunla (donanemab) affect the ability to drive or use machines?How much sodium does each 20 ml vial of Kisunla (donanemab) contain?Is Kisunla (donanemab) recommended during pregnancy?What should Kisunla (donanemab) concentrate for solution for infusion look like?What is known about donanemab use during breastfeeding?What symptoms can occur during an infusion-related reaction to donanemab?

donanemab

Read the wider context, including uses, precautions and the sources behind this medicine guide.

Read the donanemab guide

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX